No significant differences were observed in the anti-E antibody titers across IgM, IgA, and IgG isotypes among the different COVID-19 vaccine platforms (adenovector, mRNA, and protein subunit) in vaccinated individuals (Supplementary Figure S1). This evidence concerns the gene CD40LG and COVID-19.